2012-08-15T09:01:54-05:00 2011-09-30 CBIZ TOFIAS 500 BOYLSTON STREET BOSTON MA 02116 990 2010-10-01 042203836 JOSLIN DIABETES CENTER INC JOSL 6173092400 ONE JOSLIN PLACE BOSTON MA 022155306 ROSS J MARKELLO 6173092400 2012-08-14 1 CRAIG KLEIN 6177610600 2010 2016-02-24 21:20:13Z JOHN L BROOKS III ONE JOSLIN PLACE BOSTON MA 022155306 86947855 0 X WWW.JOSLIN.ORG X 1950 MA TO IMPROVE THE LIVES OF PEOPLE WITH DIABETES AND ITS COMPLICATIONS THROUGH INNOVATIVE CARE, EDUCATION AND RESEARCH THAT WILL LEAD TO PREVENTION AND CURE OF THE DISEASE. 14 11 696 118 0 0 36244094 39447164 39664322 40533855 3985342 3246561 1317258 2348879 81211016 85576459 0 4795503 0 0 48921883 46819852 296085 0 2244819 47138966 33840583 96356934 85455938 -15145918 120521 136074590 127648830 35594552 33330931 100480038 94317899 X TO IMPROVE THE LIVES OF PEOPLE WITH DIABETES AND ITS COMPLICATIONS THROUGH INNOVATIVE CARE, EDUCATION AND RESEARCH THAT WILL LEAD TO PREVENTION AND CURE OF THE DISEASE. 0 0 35985831 39262416 PATIENT CARE: JOSLIN HAS TREATED THOUSANDS OF PATIENTS OVER ITS 100+ YEAR HISTORY. PATIENTS ARE SEEN IN THE JOSLIN CLINIC FOR SERVICES THAT INCLUDE ENDOCRINOLOGY, OPHTHALMOLOGY, NEPHROLOGY, PSYCHOSOCIAL SERVICES, NUTRITION, EXERCISE PHYSIOLOGY AND OTHERS. IN ADDITION, JOSLIN HAS A PROFESSIONAL EDUCATION PROGRAM WHICH EDUCATES PHYSICIANS NATIONWIDE ON JOSLIN TREATMENT METHODS FOR PATIENTS WITH DIABETES.SEE THE COMMUNITY BENEFIT STATEMENT ON SCHEDULE O. 32761529 2299628 RESEARCH: MILLIONS OF PEOPLE WITH DIABETES THROUGHOUT THE WORLD BENEFIT DIRECTLY FROM BASIC AND CLINICAL RESEARCH CONDUCTED AT THE CENTER. APPROXIMATELY 300 RESEARCHERS EMPLOYED AT THE JOSLIN DIABETES CENTER ARE WORKING ON VARIOUS ASPECTS OF DIABETES, SEARCHING FOR WAYS TO PREVENT AND TREAT DIABETES IN ALL ITS FORMS AND ULTIMATELY FIND A CURE FOR THE DISEASE.SEE THE COMMUNITY BENEFIT STATEMENT ON SCHEDULE O. 68747360 1 1 0 0 0 0 0 0 1 1 1 0 0 1 1 0 1 0 0 1 0 0 0 1 1 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 327 1 1 696 1 0 0 0 0 0 0 0 0 0 0 X 14 11 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA AL AK AZ AR CA CT GA IL KS KY ME MD MI MS NH NJ NM NY NC OH OK OR PA RI SC TN UT WA WV VA WI CO HI MN MO ND X TIMOTHY P GARLAND 6173095744 ONE JOSLIN PLACE BOSTON MA 02215 ABRAHAMSON MARTIN J 40.00 X X 280062 0 47652 BROOKS III JOHN L 40.00 X X 0 0 0 KING GEORGE L 40.00 X X 280127 0 41644 ALLEN WALTER RAY 2.00 X 0 0 0 COOK JR JOHN J 2.00 X 0 0 0 AMENTA PETER S MD PH D 2.00 X 0 0 0 GARDINER NATHANIEL S 2.00 X 0 0 0 GROSSMAN MORELLA M 2.00 X 0 0 0 LAGASSE ANNE M 2.00 X 0 0 0 JAMES RALPH M 2.00 X 0 0 0 MCCOLLOUGH W ALAN 2.00 X 0 0 0 PETERSON JAMES L 2.00 X 0 0 0 REHNERT GEOFFREY S 2.00 X 0 0 0 SMITH RICHARD A 2.00 X 0 0 0 QUICKEL KENNETH E 40.00 X 682259 0 21404 ATTARIAN MARK A 40.00 X 188682 0 703 MARKELLO ROSS 40.00 X 224526 0 13029 CHAPMAN JOHN C 40.00 X 243202 0 1426 KAHN C RONALD 40.00 X 1211423 0 48852 SHARUK GEORGE S 40.00 X 326135 0 48005 SULLIVAN MICHAEL P 40.00 X 332296 0 44858 SCHLOSSMAN DEBORAH K 40.00 X 325437 0 28974 ARRIGG PAUL G 40.00 X 279086 0 53059 AIELLO LLOYD PAUL 40.00 X 239884 0 54722 KIMBALL RANCH C 0.00 X 388041 0 76 5001160 0 404404 99 1 1 0 MARK D CRAWFORD PO BOX 554 BILLERICA MA 01865 GENERAL CONTRACTOR 504864 DELOITTE & TOUCHE LLP 200 BERKELEY STREET BOSTON MA 02116 PUBLIC ACCOUNTANTS 373595 LIFE TECHNOLOGIES 12088 COLLECTION CENTER DRIVE CHICAGO IL 60693 BIOTECHNOLOGY TOOLS 324924 ATTAIN LLC C/O PO BOX 221374 CHANTILLY VA 20151 PROFESSIONAL SERVICES 310081 HARRIS CONNECT LLC 1511 ROUTE 22 SUITE C-25 BREWSTER NY 10509 PROFESSIONAL SERVICES 297528 16 810342 30510821 8126001 522411 39447164 SERVICE AGREEMENT 900099 22885856 22885856 ED. PROG./PUBLICATIONS 900099 15328681 15328681 RESEARCH GRANTS 900099 2299628 2299628 CLINIC PATIENT SVCS RE 900099 19690 19690 40533855 1638067 1638067 67005 67005 807562 447190 360372 360372 360372 1608494 1608494 1608494 1608494 1648319 810342 846304 802015 802015 169200 77902 91298 91298 OTHER REVENUE 900099 1028189 1028189 1028189 85576459 41562044 0 4567251 4795503 4795503 5077263 2733838 1726709 616716 32420066 28395610 3242410 782046 1561643 1296560 206855 58228 5402854 4485030 716216 201608 2358026 1957760 312344 87922 1244741 1871 1242150 720 192780 39600 153180 388972 388972 10567721 8782077 1664573 121071 320897 168004 152893 277134 123979 140215 12940 2605290 1541123 1026746 37421 1002594 874031 49639 78924 248781 172734 65955 10092 153622 153622 3057765 1808779 1205066 43920 711546 434617 276929 SUPPLIES 7676746 7427551 222274 26921 EQUIP. RENTAL/MAINT. 1820517 657681 1148091 14745 PATIENT SUBJECT COSTS 1145122 1145122 PRINTING & PUBLICATIONS 506673 426156 38 80479 PERM. RESEARCH EQUIP. 409825 409825 1509857 1069909 368882 71066 85455938 68747360 14463759 2244819 3748035 5720387 4286331 7509712 5979868 4588201 219276 108625 1229715 1314771 78992498 59144635 19899649 19847863 84955135 70904983 10326518 13540672 5430063 4113616 136074590 127648830 11890973 10254869 8034449 9153916 10800000 9500000 610979 609261 4258151 3812885 35594552 33330931 X 35317900 32351137 23536525 19952547 41625613 42014215 100480038 94317899 136074590 127648830 X 120521 -6282660 X 0 1 1 X 1 1 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 51791767 441237 -1739266 1498304 48995434 51460825 175943 3347980 3192981 51791767 44833831 2106784 4520210 51460825 0.00000 0.85800 0.14200 1 0 1072684 1072684 56099655 43312806 12786849 21809379 15831829 5977550 10780 10780 19847863 LIFE INSURANCE POLICIES 133504 F ADAGE LIMITED PARTNERSHIP 10365173 F EQUITY MUTUAL FUNDS 3041995 F 13540672 OBLIGATIONS UNDER CHARITABLE REMAINDER TRUSTS 1206006 ACCRUED ASSET RETIREMENT OBLIGATION 815699 DUE TO AFFILIATE 159758 AMOUNTS HELD AS AGENT 1631422 3812885 85576459 85455938 120521 -4316396 -4316396 -4195875 81502916 -4316396 1371396 -2945000 84447916 1128543 1128543 85576459 85698791 1371396 1371396 84327395 1128543 1128543 85455938 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: THE CENTER'S ENDOWMENT FUNDS ARE USED TO SUPPORT DIABETES RESEARCH AND PATIENT CARE. THE BOARD OF DIRECTORS VOTED TO SPEND THE INCOME EARNED ON THE ENDOWMENT AND NO MORE THAN 4% OF THE APPRECIATION ON THE ENDOWMENT FUNDS. DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: JOSLIN HAS BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE (IRS) AS AN ORGANIZATION DESCRIBED IN INTERNAL REVENUE CODE (THE "CODE") SECTION 501(C)(3) AND, THEREFORE, IS EXEMPT FROM TAXATION ON RELATED INCOME UNDER SECTION 501(A) OF THE CODE. THE IRS HAS ALSO PREVIOUSLY DETERMINED THAT THE ENTITY IS NOT A PRIVATE FOUNDATION PURSUANT TO SECTION 509(A) OF THE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES 447,190. FUNDRAISING EXPENSES 846,304. GAMING EXPENSES 77,902. PART XII, LINE 4B - OTHER ADJUSTMENTS: NET ASSETS RELEASED DESIGNATED FOR CLINIC SPENDING 1,128,543. PART XIII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES 447,190. FUNDRAISING EXPENSES 846,304. GAMING EXPENSES 77,902. PART XIII, LINE 4B - OTHER ADJUSTMENTS: NET ASSETS RELEASED DESIGNATED FOR CLINIC SPENDING 1,128,543. NORTH AMERICA 0 0 PROGRAM SERVICES DISEASE MANAGEMENT, MAINTENANCE PROGRAM 0 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES DISEASE MANAGEMENT, MAINTENANCE PROGRAM 0 SOUTH ASIA 0 0 PROGRAM SERVICES DISEASE MANAGEMENT, MAINTENANCE PROGRAM 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 HIGH HOPES GALA 1785805 306845 1478960 543159 67299 JDC ROUNDTABLE 306000 281000 25000 38086 57978 2 366856 222497 144359 36504 1348 101930 2458661 810342 1648319 36504 38086 544507 227207 846304 802015 169200 69442 8460 0 169200 69442 8460 77902 91298 MA 1 0 1 0 0.00000 1.00000 TIM GARLAND ONE JOSLIN PLACE BOSTON MA 022155306 0 HELAINE AHERN HELAINE AHERN SERVES AS VICE PRESIDENT OF DEVELOPMENT. AS SUCH, IN ADDITION TO OTHER DUTIES, SHE OVERSEES RAFFLE ACTIVITIES. X 0 0 JOSLIN CLINIC INC ONE JOSLIN PLACE BOSTON MA 02115 222984590 501(C)(3) 4795503 DEFICIT CONTRIBUTION AND DESIGNATED SPENDING 1 0 X X X X 1 0 0 0 0 0 0 0 0 ABRAHAMSON MARTIN J 275410 0 4652 0 0 0 19160 0 28492 0 327714 0 0 0 KING GEORGE L 280127 0 0 0 0 0 19160 0 22484 0 321771 0 0 0 QUICKEL KENNETH E 682259 0 0 0 0 0 19921 0 1483 0 703663 0 0 0 ATTARIAN MARK A 188682 0 0 0 0 0 0 0 703 0 189385 0 0 0 MARKELLO ROSS 149526 0 75000 0 0 0 0 0 13029 0 237555 0 0 0 CHAPMAN JOHN C 243202 0 0 0 0 0 0 0 1426 0 244628 0 0 0 KAHN C RONALD 511633 0 0 0 699790 0 19160 0 29692 0 1260275 0 0 0 SHARUK GEORGE S 267020 0 59115 0 0 0 19160 0 28845 0 374140 0 0 0 SULLIVAN MICHAEL P 329271 0 0 0 3025 0 19160 0 25698 0 377154 0 0 0 SCHLOSSMAN DEBORAH K 244610 0 80827 0 0 0 19160 0 9814 0 354411 0 0 0 ARRIGG PAUL G 279086 0 0 0 0 0 19160 0 33899 0 332145 0 0 0 AIELLO LLOYD PAUL 237138 0 2746 0 0 0 19160 0 35562 0 294606 0 0 0 KIMBALL RANCH C 0 0 0 0 388041 0 0 0 76 0 388117 0 0 0 PART I, LINE 4A RANCH C. KIMBALL TERMINATED EMPLOYMENT WITH JOSLIN DIABETES CENTER, INC. ON 8/31/09. HE RECEIVED $388,117 OF SEVERANCE PAY INCLUDING BENEFITS IN 2010. SUPPLEMENTAL INFORMATION PART III THE CENTER HAD ENTERED INTO A SPLIT-DOLLAR LIFE INSURANCE POLICY AGREEMENT WITH RESPECT TO C. RONALD KAHN, MD. THE POLICY AGREEMENT WAS INTENDED TO QUALIFY AS A LIFE INSURANCE EMPLOYEE BENEFIT PLAN DESCRIBED IN U.S. IRS RULING 64-328, 1964-2, C.B.11. THE PLAN PROVIDED LIFE INSURANCE FOR DR. KAHN AND WAS INTENDED TO BE AN UNFUNDED OR INSURED WELFARE BENEFIT PLAN WITHIN THE MEANING OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 (ERISA), TO THE EXTENT APPLICABLE. DURING CALENDAR 2010, THE CENTER AND THE EMPLOYEE AGREED TO DISSOLVE THE POLICY AND GENERATE A NEW AGREEMENT. THIS NEW AGREEMENT ESTABLISHED A VESTING SCHEDULE FOR THE PROCEEDS OF THE DISSOLVED POLICY WHICH WOULD BE PAID OUT IN THIRDS. DR. KAHN RECEIVED $699,790 DURING CALENDAR 2010 WHICH REPRESENTS TWO THIRDS OF HIS INTENDED PAYOUT. THIS AMOUNT IS REFLECTED IN FORM 990, PART VII, COLUMN D AND SCHEDULE J, PART II, COLUMN B(III). X 26 135694 BOOK VALUE AT RECEIPT X AUCTION ITEMS 1 386717 DONOR STATED VALUE 0 1 1 THIRD PARTY USE: PART I, LINE 32B: THE ORGANIZATION USES VOLUNTEER COMMITTEES FOR EVENTS THAT SOLICIT OTHER PARTIES TO OBTAIN AUCTION ITEMS. COMMUNITY BENEFIT STATEMENT FORM 990, PART III, LINE 4A & B: JOSLIN DIABETES CENTER THE GLOBAL EPIDEMIC OF DIABETES DATA PUBLISHED IN JANUARY 2011 BY THE CENTERS FOR DISEASE CONTROL (CDC), 25.8 MILLION AMERICANS NOW HAVE DIABETES. 95% OF THIS IS TYPE 2 DIABETES. IN ADDITION, AN ESTIMATED 79 MILLION U.S. ADULTS HAVE PRE-TYPE 2 DIABETES, WHICH ALSO RAISES A PERSON'S RISK OF HEART DISEASE AND STROKE. IN TOTAL, DIABETES AFFECTS 8.3 PERCENT OF AMERICANS OF ALL AGES, AND 11.3 PERCENT OF ADULTS AGED 20 AND OLDER, ACCORDING TO THE NATIONAL DIABETES FACT SHEET FOR 2011. ABOUT 27 PERCENT OF THOSE WITH DIABETES - 7 MILLION AMERICANS - DO NOT KNOW THEY HAVE THE DISEASE. PREDIABETES AFFECTS 35 PERCENT OF ADULTS AGED 20 AND OLDER. COMPARE THESE NUMBERS TO THE PREVIOUS NUMBERS FROM 2008 WHEN THE CDC ESTIMATED THAT 23.6 MILLION AMERICANS HAD DIABETES AND ANOTHER 57 MILLION ADULTS HAD PREDIABETES. SOME OTHER FRIGHTENING STATISTICS: IN THE PAST YEAR ALONE, AN ESTIMATED 1.9 MILLION AMERICANS WERE DIAGNOSED WITH DIABETES. FURTHERMORE, HALF OF AMERICANS AGED 65 AND OLDER HAVE PREDIABETES, AND NEARLY 27 PERCENT HAVE DIABETES. IN ADDITION, ABOUT 215,000 AMERICANS YOUNGER THAN AGE 20 HAVE DIABETES. WHILE MOST OF THIS IS TYPE 1 DIABETES, IN THE 10-19 AGE GROUP, ALMOST 30% IS CONSIDERED TYPE 2 DIABETES. DIABETES IS ASSOCIATED WITH AN INCREASED RISK FOR A NUMBER OF DEVASTATING COMPLICATIONS INCLUDING HEART DISEASE AND STROKE, KIDNEY DISEASE, BLINDNESS AND AMPUTATIONS. OVERALL, THE RISK FOR DEATH AMONG PEOPLE WITH DIABETES IS ABOUT TWICE THAT OF PEOPLE WITHOUT DIABETES OF SIMILAR AGE. INCREASES IN TYPES 1 AND 2 DIABETES, AS WELL AS OBESITY, ARE ALSO BEING OBSERVED IN CHILDREN AND ADOLESCENTS PRESENTING FUTURE CHALLENGES TO THE HEALTHCARE SYSTEM. IN ADDITION TO THE HUMAN TOLL, THE FINANCIAL BURDEN ASSOCIATED WITH DIABETES IS STAGGERING. BETWEEN HEALTHCARE COSTS AND LOST PRODUCTIVITY, DIABETES IS ESTIMATED TO COST THE NATIONAL ECONOMY $218 BILLION ANNUALLY. THE ADA HAS ESTIMATED THAT ONE OUT OF EVERY FIVE HEALTHCARE DOLLARS IS SPENT CARING FOR SOMEONE WITH DIABETES. JOSLIN IS MEETING THE CHALLENGE OF THE GLOBAL EPIDEMIC OF DIABETES JOSLIN DIABETES CENTER IS THE WORLD'S LARGEST DIABETES RESEARCH CENTER, DIABETES CLINIC AND PROVIDER OF DIABETES EDUCATION. AMONG THE HARVARD MEDICAL SCHOOL AFFILIATED INSTITUTIONS, JOSLIN IS ONE OF THE MOST RESEARCH-INTENSIVE ACADEMIC MEDICAL CENTERS AND IS UNIQUE IN ITS SOLE FOCUS ON DIABETES. THIS CONCENTRATED FOCUS ON A SINGLE DISEASE ALLOWS IT TO RAPIDLY DISCOVER, CREATE AND DISTRIBUTE NEW KNOWLEDGE ABOUT DIABETES PREVENTION, TREATMENT OPTIONS AND RESEARCH TOWARD A CURE. FOUNDED IN 1898 BY ELLIOTT P. JOSLIN, M.D., JOSLIN TODAY HAS ALMOST 700 EMPLOYEES WORKING IN THREE MAJOR DIVISIONS: - JOSLIN RESEARCH, A HIGHLY COLLABORATIVE TEAM OF MORE THAN 300 PEOPLE WITH MORE THAN 46 FACULTY LEVEL INVESTIGATORS UNDERTAKING THE LARGEST RESEARCH PROGRAM AIMED AT PREVENTING AND CURING TYPE 1 AND TYPE 2 DIABETES AND THEIR LONG-TERM COMPLICATIONS. - JOSLIN CLINIC, INC., THE WORLD'S FIRST AND MOST RESPECTED DIABETES CARE FACILITY, WHICH CARES FOR 22,000 ADULT AND PEDIATRIC PATIENTS A YEAR. - JOSLIN STRATEGIC INITIATIVES, WHICH DEVELOPS AND MARKETS INNOVATIVE PROGRAMS, PRODUCTS AND SERVICES THAT EXPAND THE AVAILABILITY OF JOSLIN KNOWLEDGE AND EXPERTISE TO PEOPLE WITH DIABETES AND THE CLINICIANS WHO CARE FOR THEM. JOSLIN IS ONE OF THE MOST SIGNIFICANT ASSETS TO THE PATIENT AND MEDICAL COMMUNITY IN BOSTON, A CITY REGARDED AS THE COUNTRY'S PREEMINENT MEDICAL CENTER. JOSLIN'S INVALUABLE EDUCATIONAL PROGRAMS AND CARE RESOURCES BENEFIT PATIENTS IN THE SURROUNDING NEIGHBORHOOD, THE CITY OF BOSTON AND THE NEW ENGLAND REGION. PATHWAYS OF DISCOVERY: ULTIMATE IMPACT IS THROUGH RESEARCH THE JOSLIN RESEARCH TEAM REPRESENTS THE MOST COMPREHENSIVE AND DYNAMIC RESEARCH PROGRAM DEDICATED EXCLUSIVELY TO DIABETES ANYWHERE IN THE WORLD. THERE IS NO INSTITUTION QUITE LIKE JOSLIN, WHERE RESEARCH IS DIRECTLY COUPLED TO PATIENT CARE AND EDUCATION, WHICH FACILITATES IMPROVING THE LIVES OF PEOPLE WITH DIABETES. JOSLIN INVESTIGATORS, WHO ENGAGE IN BOTH BASIC AND CLINICAL RESEARCH ACROSS THE SECTIONS INTO WHICH THE RESEARCH DIVISION IS ORGANIZED, ARE ADVANCING SCIENCE AT AN UNUSUALLY FAST PACE DUE TO JOSLIN'S UNIQUE ENVIRONMENT. AT ANY GIVE TIME THERE ARE FIVE COLLABORATIONS - ON AVERAGE - BETWEEN PRINCIPAL INVESTIGATORS, RESULTING IN LONGITUDINAL RESEARCH ADVANCEMENTS AND PROGRESSION TOWARDS IMPROVING CARE AND FINDING A CURE. FROM UNDERSTANDING THE INTERFACE BETWEEN DIABETES AND GENETICS, TO THE ROLE OF INFLAMMATION IN DIABETES, THE MORE THAN 300 SCIENTISTS AT JOSLIN ARE DEDICATED TO PURSUING INNOVATIVE PATHWAYS OF DISCOVERY TO PREVENT, TREAT AND CURE TYPE 1 AND TYPE 2 DIABETES AND THEIR COMPLICATIONS, WITH THE ULTIMATE GOAL OF A WORLD WITHOUT DIABETES. SOME OF THE MOST IMPORTANT HISTORICAL DISCOVERIES AND IMPROVEMENTS IN DIABETES CARE WORLDWIDE-RECOGNITION THAT TIGHT BLOOD GLUCOSE CONTROL CAN SLOW OR PREVENT DIABETES COMPLICATIONS, CREATION OF TREATMENT PROTOCOLS TO ENABLE WOMEN WITH DIABETES TO HAVE HEALTHY BABIES, THE IDENTIFICATION OF MARKERS FOR PRE-DIABETES, AND PIONEERING LASER SURGERY FOR DIABETIC EYE DISEASE-WERE DEVELOPED AT JOSLIN. OUR RESEARCH HAS AN IMPACT ON PEOPLE WITH DIABETES LOCALLY, NATIONALLY AND INTERNATIONALLY-IN THE AREAS OF TYPE 1 DIABETES, TYPE 2 DIABETES AND DIABETES COMPLICATIONS. FOR EXAMPLE, INVESTIGATORS IN SEVERAL JOSLIN RESEARCH SECTIONS ARE EXPLORING THE COMPLEXITY OF DIABETES COMPLICATIONS, SUCH AS CARDIOVASCULAR, KIDNEY AND EYE DISEASE. WHERE ELSE COULD YOU FIND A DATABASE OF BIOLOGICAL AND PSYCHOLOGICAL DATA FROM PATIENTS WITH DIABETES, STRETCHING BACK DECADES? JOSLIN CLINIC RECORDS HAVE BEEN INVALUABLE IN STUDYING HOW COMPLICATIONS DEVELOP AND PROGRESS OVER TIME. GENETICS RESEARCHERS AT JOSLIN ARE STUDYING WHAT CHANGES IN THE GENES MAKE PEOPLE WITH DIABETES SUSCEPTIBLE TO THESE COMPLICATIONS. OTHER INVESTIGATORS FOCUS ON THE IMPACT OF INSULIN ON BLOOD VESSELS. AND STILL OTHERS SPECIALIZE IN THE MOLECULAR MECHANISMS THAT LEAD TO LONG-TERM COMPLICATIONS. INCLUDED IN THE MANY AREAS OF SCIENTIFIC EXPLORATION IS PEDIATRIC RESEARCH. AT A BASIC RESEARCH LEVEL, WE ARE WORKING ON UNTANGLING THE COMPLEX COMBINATION OF GENES AND ENVIRONMENT THAT RESULTS IN THE DESTRUCTION OF INSULIN-MAKING CELLS IN THE PANCREAS, THE CAUSE OF TYPE 1 DIABETES. WE ARE ALSO EXPLORING THE POTENTIAL OF STEM CELLS AND ISLET CELL TRANSPLANTATION. WE WANT TO UNDERSTAND TYPE 2 DIABETES BETTER AS WELL, AS IT IS INCREASING IN ALARMING NUMBERS AMONG CHILDREN AND TEENS. THERAPIES FOR TYPE 2 DIABETES ARE GEARED TO ADULTS, AS THIS WAS FORMERLY CONSIDERED JUST A DISEASE OF ADULTHOOD. JOSLIN IS A PRINCIPAL SITE FOR A NATIONAL STUDY THAT SEEKS TO IDENTIFY THE MOST EFFECTIVE THERAPY FOR THE EARLY STAGES OF TYPE 2 DIABETES IN YOUNGSTERS. COMPLEMENTING OUR BASIC RESEARCH WORK IS OUR CLINICAL RESEARCH. APPROXIMATELY 30 TO 40 PERCENT OF ALL RESEARCH AT JOSLIN IS CLINICAL RESEARCH. MORE THAN 150 CLINICAL TRIALS AND HUMAN SUBJECT STUDIES ARE UNDER WAY AT ANY GIVEN TIME, RANGING FROM STUDIES OF PROMISING NEW DRUGS TO THOSE EVALUATING THE IMPACT OF LIFESTYLE CHANGES SUCH AS WEIGHT LOSS AND INCREASED PHYSICAL ACTIVITY. JOSLIN KNOWLEDGE ACROSS THE GLOBE JOSLIN SCIENTISTS KNOW THAT A RESEARCH BREAKTHROUGH CAN AFFECT THE HEALTH AND LIVES OF MILLIONS OF PEOPLE. AND SO CAN EDUCATION. SINCE 1987, JOSLIN HAS COMBINED ITS CLINICAL, RESEARCH AND EDUCATION INITIATIVES WITH THE GOAL OF DEVELOPING HEALTH SOLUTIONS THAT GENERATE LARGE-SCALE BENEFITS FOR ORGANIZATIONS THAT SERVE DIABETES PATIENTS, PROVIDERS AND CONSUMERS AROUND THE WORLD. THROUGH JOSLIN'S EDUCATIONAL PROGRAMS, WE SEEK TO IMPROVE THE PUBLIC HEALTH AT LARGE. THIS IS ACHIEVED THROUGH A VARIETY OF EDUCATIONAL OUTLETS. JOSLIN HAS ONE OF THE LARGEST DIABETES TRAINING PROGRAMS IN THE WORLD, EDUCATING 150 M.D. AND PH.D. RESEARCHERS ANNUALLY. THERE ARE MORE THAN 1,500 JOSLIN M.D. ALUMNI WORKING AROUND THE WORLD. JOSLIN'S PROFESSIONAL EDUCATION ACTIVITIES REACH NEARLY 50,000 PRIMARY CARE PHYSICIANS AND ALLIED HEALTH PROFESSIONALS ANNUALLY. THROUGH THIS AUDIENCE, JOSLIN HAS ACHIEVED NATIONAL VISIBILITY AND A REPUTATION FOR EXCELLENCE IN PRODUCING ACTIVITIES THAT HAVE MEASURABLE IMPACT ON PHYSICIAN PERFORMANCE AND PATIENT OUTCOMES. THESE PROGRAMS EMPOWER HEALTHCARE PROVIDERS TO MORE EFFECTIVELY SET THE STANDARDS OF DIABETES CARE FOR THEIR COMMUNITIES, PROVIDE OPTIMAL MANAGEMENT OF ALL DIABETES PATIENTS, IMPROVE HEALTHCARE OUTCOMES AND ENHANCE PATIENT QUALITY OF LIFE. EDUCATION IS PROVIDED IN A VARIETY OF FORMATS INCLUDING LIVE WEEKEND AND EVENING DIDACTIC SYMPOSIA, INTERACTIVE PATIENT ENCOUNTER SIMULATIONS, BOTH LIVE AND CONTINUING ONLINE, WEB-BASED SELF-STUDIES, MOBILE APPLICATIONS AND PERFORMANCE IMPROVEMENT PROGRAMS. SINCE 2002, JOSLIN PROFESSIONAL EDUCATION HAS REACHED MORE THAN 500,000 HEALTHCARE PROVIDERS. WE KNOW THAT 80 PERCENT OF PEOPLE WITH DIABETES SEE THEIR PRIMARY CARE PROVIDERS FOR THEIR DIABETES CARE. THROUGH OUR PROFESSIONAL EDUCATION PROGRAMS, WE ARE REACHING THESE PROVIDERS, WITH THE GOAL OF ENSURING THAT ALL PATIENTS WITH DIABETES GET THE BEST CARE POSSIBLE. AND IT IS ALLIED HEALTH PROFESSIONALS IN PARTICULAR WHO ARE NOW THE PRIMARY PROVIDER OF DIABETES EDUCATION FOR PEOPLE WITH DIABETES. THEY PROVIDE CONTINUING SUPPORT AND ADVICE ON BLOOD GLUCOSE AND A1C MONITORING, MEDICATION MANAGEMENT, ACUTE COMPLICATION MANAGEMENT, CHRONIC COMPLICATION PREVENTION AND MANAGEMENT, PSYCHOSOCIAL ASSESSMENT AND ISSUES, MEAL PLANNING, NUTRITION MANAGEMENT AND PHYSICAL ACTIVITY. WE PROVIDE A PRACTICAL FOCUS ON 'SYSTEMS IMPROVEMENT IN THE PRIMARY CARE SETTING' AS OPPOSED TO JUST IMPARTING INDIVIDUAL KNOWLEDGE. AS A RESULT, THE ALLIED HEALTH PROFESSIONAL IS AN INTEGRAL TEAM MEMBER IN PROMOTING OPTIMAL DIABETES CARE. THROUGH ALL ACTIVITIES WE FOCUS ON EDUCATION, SUPPORT, TOOLS AND RESOURCES TO ENABLE THE ALLIED HEALTH PROFESSIONAL TO BE A PART OF A MORE EFFICIENT AND EFFECTIVE SYSTEM OF CARE, REGARDLESS OF THE CARE DELIVERY ENVIRONMENT. JOSLIN HAS DEVELOPED A NUMBER OF CLINICAL GUIDELINES TO HELP HEALTHCARE PROVIDERS, BOTH AT JOSLIN AND IN THE COMMUNITY, IMPROVE THE TREATMENT AND CARE OF INDIVIDUALS WITH DIABETES. EXPERTS FROM JOSLIN DEVELOPED THESE GUIDELINES, WHICH ARE RECOMMENDATIONS FOR CLINICAL PRACTICE AND TREATMENT, AND THEY ARE UNIQUE IN THAT THEY ARE CLEAR, CONCISE AND EASY TO USE. THEY ARE ALSO FREE AND EASILY ACCESSED VIA THE JOSLIN WEB SITE. THE PRIMARY OBJECTIVE OF JOSLIN DIABETES CENTER'S CLINICAL GUIDELINES IS TO SUPPORT CLINICAL PRACTICE AND INFLUENCE CLINICAL BEHAVIORS OF PROVIDERS SO THAT OUTCOMES ARE IMPROVED AND PATIENT EXPECTATIONS ARE INFORMED AND REASONABLE. THEY SERVE AS THE BASIS FOR ALL OF JOSLIN'S CLINICAL PROGRAMS, CARE PATHWAYS, PROFESSIONAL AND PATIENT EDUCATION PROGRAMS AND SELF-MANAGEMENT ENDURING MATERIALS AT JOSLIN IN BOSTON, AT OUR AFFILIATES ACROSS THE COUNTRY AND IN OUR OUTREACH PROGRAMS WORLDWIDE. JOSLIN'S PUBLICATIONS OFFER A WIDE RANGE OF BOOKS, COOKBOOKS, VIDEOTAPES, ONLINE SERVICES AND OTHER EDUCATIONAL MATERIALS FOR PEOPLE WITH BOTH TYPE 1 DIABETES AND TYPE 2 DIABETES AND THE PHYSICIANS AND ALLIED HEALTH PROVIDERS WHO CARE FOR THEM. BOOKS ARE AUTHORED BY JOSLIN DIABETES CENTER STAFF, THUS PROVIDING THE JOSLIN EXPERTISE, REPUTATION AND EXPERIENCE. JOSLIN'S PUBLICATIONS ARE AVAILABLE IN A RANGE OF LITERACY LEVELS FROM FOURTH GRADE TO HIGH SCHOOL LEVEL, AND A FULL LIST OF OUR PUBLICATIONS CAN BE FOUND ON WWW.JOSLIN.ORG/STORE. JOSLIN'S AFFILIATED CENTER PROGRAM CONSISTS OF 42 HOSPITAL-BASED AFFILIATES AND SATELLITES IN THE UNITED STATES, WHICH PROVIDE MORE THAN 176,000 ANNUAL ADULT PATIENT VISITS AND 9,000 PEDIATRIC VISITS. JOSLIN ALSO HAS AN INTERNATIONAL AFFILIATE IN KUWAIT AND ANOTHER IN CANADA. WORKING WITH DOMESTIC AND INTERNATIONAL HOSPITALS AND HEALTHCARE SYSTEMS, THESE CENTERS PROVIDE A CONTINUUM OF CARE BASED ON JOSLIN STANDARDS OF PRACTICE AND QUALITY-THAT IS, EXPERT DIABETES EDUCATION MANAGEMENT THAT CAN PREVENT COMPLICATIONS. THROUGH OUR AFFILIATED CENTER PROGRAM, WE REACH THE COUNTLESS NUMBER OF PATIENTS WHO ARE TOUCHED BY DIABETES. A TYPICAL JOSLIN AFFILIATED PROGRAM INCLUDES: - MEDICAL DIRECTOR AND PHYSICIANS WHO ARE BOARD CERTIFIED IN INTERNAL MEDICINE, OR INTERNAL MEDICINE AND ENDOCRINOLOGY. - NURSING STAFF WHO ARE CERTIFIED DIABETES EDUCATORS. - DIETITIANS WHO ARE CERTIFIED DIABETES EDUCATORS. - ACCESS TO STAFF IN THE FOLLOWING AREAS (EITHER AS PART OF THE JOSLIN PROGRAM OR THROUGH REFERRAL TO THE HOSPITAL): EXERCISE SPECIALIST; MENTAL HEALTH SPECIALIST; PODIATRIST; EYE SPECIALIST; OTHER SPECIALISTS, SUCH AS NEPHROLOGY, CARDIOLOGY, VASCULAR MEDICINE, ETC. - A WIDE RANGE OF PROGRAMS AND EDUCATIONAL MATERIALS FOR USE WITH PATIENTS. - A COMPREHENSIVE TRAINING AND EDUCATION PROGRAM FOR STAFF. TO PROVIDE BROAD ACCESS FOR INDIVIDUALS SEEKING INFORMATION AND EDUCATION ABOUT DIABETES, JOSLIN DIABETES CENTER PROVIDES MANY RESOURCES VIA OUR WEB SITE. WE OFFER INTERACTIVE ONLINE CLASSES ABOUT DIABETES, PROFESSIONAL EDUCATION SYMPOSIUM, DISCUSSION BOARDS, AN DIABETES SELF-MANAGEMENT BLOG AND A BOOKSTORE THROUGH OUR WEB SITE. THE AREAS OF EDUCATIONAL CONTENT ON JOSLIN'S WEB SITE INCLUDE THE FOLLOWING: - WORDS AND PHRASES - DIABETES-RELATED WORDS AND PHRASES. - BEGINNER'S GUIDE - A SERIES OF ARTICLES ON TOPICS THAT ARE USEFUL TO THOSE NEWLY DIAGNOSED WITH DIABETES AND WHO NEED TO QUICKLY LEARN THE BASIC INFORMATION AND ACQUIRE THE BASIC SELF-MANAGEMENT SKILLS. THESE ARTICLES INCLUDE: - GENERAL DIABETES FACTS AND INFORMATION - HOW IS DIABETES DIAGNOSED? - WHAT IS PRE-DIABETES? - WILL DIABETES GO AWAY? - HOW DO I PREVENT COMPLICATIONS? - ARE COMPLICATIONS INEVITABLE? - CAN I TREAT DIABETES WITHOUT DRUGS? - HOW CAN I AVOID HAVING TO INJECT INSULIN? - DIABETES CHECKLIST - QUESTIONS TO ASK YOUR DOCTOR - DIABETES CHECKLIST - WHAT YOU NEED TO KNOW - MANAGING YOUR DIABETES - A WIDE-RANGING SERIES OF ARTICLES COVERING VARIOUS ASPECTS OF DIABETES SELF-MANAGEMENT ON INSULIN, ORAL MEDICATIONS, NUTRITION, PHYSICAL ACTIVITY, DIABETES COMPLICATIONS AND FEELINGS ABOUT DIABETES. TAKEN ALL TOGETHER, JOSLIN'S HANDS-ON CARE, EDUCATION AND OUTREACH PROGRAMS IMPROVE QUALITY OF CARE FOR MORE THAN TWO MILLION PATIENTS AROUND THE WORLD. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 IS REVIEWED BY MEMBERS OF THE FISCAL SERVICES DEPARTMENT FOR COMPLETENESS AND ACCURACY. ONCE REVIEWED AND APPROVED BY FINANCE, A COPY OF THE FORM AS IT WILL BE FILED WITH THE INTERNAL REVENUE SERVICE WILL BE E-MAILED TO THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE GENERAL COUNSEL'S OFFICE DISTRIBUTES AN ANNUAL DISCLOSURE FORM TO ALL OFFICERS, TRUSTEES AND EMPLOYEES ANNUALLY. THE INFORMATION DISCLOSED IS REVIEWED BY THE GENERAL COUNSEL AND IF A POTENTIAL CONFLICT EXISTS THE INDIVIDUAL SHALL REFRAIN FROM ACTIVE PARTICIPATION IN ANY DECISIONS CONCERNING THE MATTER. REVIEWS ARE CONDUCTED BY THE COMMITTEE AS DEFINED BELOW. THE DISCLOSURE FORMS OF THE VICE PRESIDENTS WILL BE REVIEWED BY THE GENERAL COUNSEL AND THE PRESIDENT, THE DISCLOSURE FORM OF THE PRESIDENT WILL BE REVIEWED BY THE GENERAL COUNSEL AND THE CHAIR OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 15 EXECUTIVE COMPENSATION INCLUDES THE CEO AND THE SENIOR LEADERSHIP TEAM. PAY FOR THE CEO IS DETERMINED BY THE BOARD. THE HUMAN RESOURCE DEPARTMENT PROVIDES SURVEY DATA AS REQUESTED. SENIOR LEADERSHIP TEAM PAY IS DETERMINED BY THE CEO WITH SURVEY DATA PROVIDED BY HR. EXECUTIVE COMPENSATION IS REVIEWED ANNUALLY BY THE COMPENSATION COMMITTEE OF THE BOARD. IN ALL CASES, COMPENSATION IS DETERMINED BY INDEPENDENT PERSONS. INDIVIDUALS ARE PROHIBITED FROM ACTIVE PARTICIPATION IN ANY DECISIONS REGARDING THEIR OWN COMPENSATION FORM 990, PART VI, SECTION C, LINE 19 THE FORM 990 AND THE AUDITED FINANCIAL STATEMENTS ARE AVAILABLE FOR REVIEW AT THE FISCAL SERVICES OFFICE AND THE MASSACHUSETTS ATTORNEY GENERAL'S WEBSITE. THEY ARE ALSO AVAILABLE IN AN ELECTRONIC FORMAT UPON REQUEST. THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND THE WHISTLEBLOWER POLCIY ARE AVAILABLE FOR REVIEW AT THE OFFICE OF THE GENERAL COUNSEL OR IN AN ELECTRONIC FORMAT UPON REQUEST. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED LOSSES ON INVESTMENTS: -4,316,396. ACCUMULATED CRICO DIVIDEND REMOVED FOR TAX PURPOSES AND NOT ON BOOKS -1,966,264. TOTAL TO FORM 990, PART XI, LINE 5: -6,282,660. JOSLIN CLINIC INC ONE JOSLIN PLACE BOSTON MA 022155306 222984590 DIABETES CLINIC MA 501(C)(3) LINE 11A, I N/A 1 JOSLIN TECHNOLOGIES LLC ONE JOSLIN PLACE BOSTON MA 022155306 364695829 MEDICAL RESEARCH MA 501(C)(3) LINE 4 N/A 1 CHARITABLE REMAINDER TRUST ONE JOSLIN PLACE BOSTON MA 022155306 043418528 TRUST MA N/A T 74962 459931 0.69470 CHARITABLE REMAINDER TRUST ONE JOSLIN PLACE BOSTON MA 022155306 776174823 TRUST MA N/A T 3023 25270 0.63070 POOLED INCOME FUND ONE JOSLIN PLACE BOSTON MA 022155306 046431421 TRUST MA N/A T 993 360681 0.60730 CHARITABLE REMAINDER TRUST ONE JOSLIN PLACE BOSTON MA 022155306 046797045 TRUST MA N/A T 43275 0.53060 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 JOSLIN CLINIC INC B 4795503 BOOK VALUE JOSLIN CLINIC INC I 5024287 BOOK VALUE JOSLIN CLINIC INC K 17861569 BOOK VALUE PART IV: ACTUAL TRUST NAMES HAVE BEEN OMITTED TO PROTECT THE PRIVACY OF THE CONTRIBUTORS. SUCH INFORMATION IS AVAILABLE TO THE IRS UPON REQUEST.